1. What is the Chemxpert database?

Chemxpert database is a techno-commercial information platform developed and operated by Lifescience Intellipedia Pvt. Ltd. Our data provides valuable insights regarding sourcing, marketing, development, and regulatory functions for the entire Lifescience industry. The different industries covered by our data encompass APIs, FDFs, pharma intermediates, paints, dyes, polymers, biotechnology, biochemical, food additives, nutraceuticals, etc.

2. How can I subscribe to the Chemxpert database?

You can gain access to the Chemxpert database after subscribing to it by visiting this link: - https://chemxpert.com/pricing

3. How many countries' data is available on your portal?

The Chemxpert database covers more than 200 countries. We are working in the direction of expanding our data coverage in more countries.

4. What are the different sources you use for obtaining information?

The different sources we use for data collection are as follows: - • Primary researc • DMF, ANDA, & CEP list • Conferences, Exhibitions, & Tradeshow • Company annual reports • DMF, ANDA, & CEP list • Subject matter experts & KOL survey. Apart from these, our other valuable sources include application-wise manufacturers list, subscribed and non-subscribed databases, corporate partners, US FDA Orange book, publicly available sources, industry associates, national statistics, regulatory websites, etc. You can gain access to the Chemxpert database after subscribing to it by visiting this link: -https://chemxpert.com/sources

5. What is the expected time for account activation?

Your Chemxpert account will be activated instantly if the payment is made through our website. If you choose to use RTGS, NEFT, or IMPS systems for payment, your account will be activated within 24 hours.

15 Mar 2024
Admin
News Article

Radyus Research & Southern Research Forms Partnership

Radyus Research and Southern Research Form Strategic Partnership to Drive Life Sciences Commercialization

Overview

Radyus Research, headquartered in Atlanta, Georgia, is thrilled to announce a groundbreaking strategic alliance with Southern Research, a prominent contract research organization based in Birmingham with over eight decades of expertise in drug discovery and development. This partnership signifies a significant leap forward in advancing life sciences commercialization within the Southeast region. The collaboration aims to capitalize on the strengths of both entities to deliver a comprehensive suite of services to clients, encompassing fully integrated preclinical solutions.

Holistic Solutions by Collab

By merging Southern Research's renowned laboratory research capabilities with Radyus Research's innovative planning and project management methodologies, this partnership will offer clients a holistic solution for navigating the complexities of life sciences commercialization.

Words from CEO: Southern Research

"We are delighted to foster synergy within the Southeast's biotech sector," stated Josh Carpenter, CEO of Southern Research. "Radyus Research brings unique expertise that complements our own. Together, we will closely collaborate to propel our partners' therapeutic endeavors forward with a compelling array of combined services."

Objective of Collaboration

The primary objective of this collaboration is to cultivate a vibrant ecosystem for life sciences firms in the region.
By providing a comprehensive range of services under one roof, clients can benefit from seamless integration of preclinical services, spanning drug discovery, development, clinical trials, regulatory affairs, and manufacturing support.

Words from CEO: Radyus Research

"We are excited to forge this strategic alliance with Southern Research,"" remarked Marta New, CEO of Radyus Research. "Our collective expertise will not only elevate the services we offer but also create fresh opportunities for life sciences companies to thrive in our region. This partnership underscores our dedication to fostering innovation and expediting the journey from concept to market."

Praises from Georgia Bio CEO

Maria Thacker Goethe, President & CEO of Georgia Bio, shares enthusiasm for this collaborative regional ecosystem initiative: "The Southeast is witnessing rapid growth in startups with groundbreaking and impactful technological innovations. Effective partnerships like this between Radyus Research and Southern Research are crucial to the evolving landscape in the region, showcasing innovative collaboration methods."

Client-oriented Services

Clients can anticipate a seamless experience, gaining access to a comprehensive range of consulting, project management, and laboratory testing services tailored to their specific requirements in drug development.
From initial research and development to preclinical toxicology testing and regulatory approval, the combined efforts of Southern Research and Radyus Research will provide unwavering support at every stage of the process.

Let’s apply Data-Driven Pricing to Your APIs

Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.

Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.

Start using market intelligence today and allow yourself to be in control in the API market.

Check it out today and make more informed sourcing decisions! Learn More!